Sigma-Aldrich Corporation  

(Public, NASDAQ:SIAL)   Watch this stock  
Find more results for NYSE:SIAL
Pre-market: 139.97 +0.21 (0.15%)
Nov 18, 8:31AM EST  
NASDAQ real-time data - Disclaimer
Currency in USD
Range     -
52 week 135.33 - 140.03
Open     -
Vol / Avg. 0.00/1.03M
Mkt cap 16.77B
P/E 34.29
Div/yield 0.23/0.66
EPS 4.08
Shares 119.99M
Beta 0.46
Inst. own 82%
Feb 10, 2016
Q4 2015 Sigma-Aldrich Corp Earnings Release (Estimated) - 9:30AM EST - Add to calendar
Nov 3, 2015
Q3 2015 Sigma-Aldrich Corp Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q3 (Sep '15) 2014
Net profit margin 16.22% 17.95%
Operating margin 23.04% 24.45%
EBITD margin - 30.41%
Return on average assets 10.47% 12.50%
Return on average equity 13.72% 16.60%
Employees 9,800 -
CDP Score - 99 A-


3050 Spruce St
ST. LOUIS, MO 63103-2530
United States - Map
+1-314-7715765 (Phone)
+1-302-6745266 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money


Sigma-Aldrich Corporation is a life science and high technology company. The Company develops, manufactures, purchases and distributes a range of biochemical and organic chemical products, kits and services that are used in scientific research. It manufactures and distributes around 250,000 chemicals, biochemical and other essential products and approximately 46,000 equipment products. Its business unit structure is aligned into three business units: Research, Applied and SAFC Commercial. Its brands include Sigma-Aldrich, Sigma, Aldrich, Fluka, Riedel-de Haen, Supelco, SAFC, SAFC Biosciences, SAFC Hitech, Genosys, Proligo, Pharmorphix, Cerilliant, Vetec, BioReliance and Cell Marque. It offers its products and services to research and applied labs, pharmaceutical companies, universities, commercial laboratories, industrial companies, biotechnology companies and non-profit organizations, among others. It operates in around 37 countries and sells into approximately 160 countries.